Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease-authors' reply

被引：0
|
作者：
Atia, Ohad [1 ]
Goren, Idan [2 ,3 ,4 ]
Yanai, Henit [2 ,3 ]
机构：
[1] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 10期
关键词：
D O I：
10.1111/apt.17504
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1184 / 1185
页数：2
相关论文
共 50 条
  • [1] Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1183 - 1183
  • [2] Letter: Bowel Preparation Quality in Patients With Crohn's Disease-Authors' Reply
    Solitano, Virginia
    Zou, Guangyong
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 236 - 237
  • [3] 5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study
    Atia, Ohad
    Goren, Idan
    Fischler, Tali Sharar
    Weisband, Yisca Loewenberg
    Greenfeld, Shira
    Kariv, Revital
    Ledderman, Natan
    Matz, Eran
    Rimon, Ramit Magen
    Dotan, Iris
    Turner, Dan
    Yanai, Henit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (09) : 1004 - 1013
  • [4] Letter: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease-Authors' reply
    Feathers, A.
    Swaminath, A.
    Ananthakrishnan, A. N.
    Falzon, L.
    Li Ferry, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (10) : 1026 - 1027
  • [5] Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply
    van de Meeberg, Maartje M.
    Fidder, Herma H.
    de Jonge, Robert
    Bouma, Gerd
    Calasan, Maja Bulatovic
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (01) : 120 - 121
  • [6] Adding 5-Aminosalicylate to Immunomodulators Showed No Additional Benefit in Crohn's Disease
    Kim, K. -J.
    Kwak, M. S.
    Soh, J. S.
    Cho, D. -H.
    Park, S. H.
    Byeon, J. -S.
    Ye, B. D.
    Myung, S. -J.
    Yang, D. -H.
    Yang, S. -K.
    Kim, J. H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S325 - S326
  • [7] Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease
    Noureldin, Mohamed
    Cohen-Mekelburg, Shirley
    Mahmood, Asadullah
    Stidham, Ryan
    Higgins, Peter D. R.
    Govani, Shail
    Deshpande, Amar R.
    Waljee, Akbar K.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) : 516 - 521
  • [8] Letter: the role of stent in the treatment of Crohn's disease strictures - authors' reply
    Loras, C.
    Perez Roldan, F.
    Gornals, J. B.
    Barrio, J.
    Igea, F.
    Gonzalez-Huix, F.
    Gonzalez Carro, P.
    Perez Miranda, M.
    Espinos, J. C.
    Fernandez-Banares, F.
    Esteve, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 503 - 504
  • [9] Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
    Chapman, Thomas P.
    Frias Gomes, Catarina
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1621 - 1621
  • [10] Letter: diagnostic delay in inflammatory bowel disease-Authors' reply
    Pollok, Richard
    Baillie, Samantha
    Jayasooriya, Nishani
    Blackwell, Jonathan
    Petersen, Irene
    Bottle, Alex
    Saxena, Sonia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1205 - 1206
12345